Literature DB >> 10719097

Donor finger morbidity in cross-finger flaps.

P Paterson1, O G Titley, J D Nancarrow.   

Abstract

We reviewed 16 patients who had cross-finger flap procedures carried out between 1991 and 1996 at the West Midlands Regional centre for Plastic and Reconstructive Surgery. We looked specifically at the donor finger morbidity of each patient with a median follow up interval of 43 months.At follow up there were 10 patients with cold intolerance, eight patients with subjective joint stiffness and a documented reduced range of finger joint movement. Skin graft reconstruction of the secondary defect was associated with poor colour match in eight cases (seven hyperpigmented, one hypopigmented) and visible contour deformity in eight cases. There were no clinically significant differences between split skin graft or full thickness skin graft for donor finger reconstruction. Although cross-finger flaps may provide soft tissue cover in a variety of finger pulp injuries, these results show an alarming incidence of donor finger morbidity associated with such procedures.

Entities:  

Mesh:

Year:  2000        PMID: 10719097     DOI: 10.1016/s0020-1383(99)00205-3

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  3 in total

1.  [The deepithelialized cross-finger flap: a good method for covering large dorsal finger defects].

Authors:  J Dabernig; B Shilov; O Schumacher; A J Turner; N Stirn; W Dabernig; C Lenz; J Schaff
Journal:  Unfallchirurg       Date:  2006-08       Impact factor: 1.000

2.  Reliability of Perforator-based UPM Flap for Coverage of Little Finger and Dorsal Hand Defect.

Authors:  Mina A Estawrow; Ahmed M Gad
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-02-22

3.  Double cross finger flaps from the middle to the index or ring finger: A case series of 4 patients with an emphasis on donor finger morbidity.

Authors:  Omar M Al-Qattan; Abdulaziz A Almobarak; Mohammad M Al-Qattan
Journal:  Int J Surg Case Rep       Date:  2018-03-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.